Related Experiment Video
Updated: Dec 10, 2025
Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
Published on: June 13, 2019
A Genetically Engineered Mouse Model of Malignant Testicular Germ Cell Tumors
Amy M Lyndaker1,2, Timothy M Pierpont1, Amanda R Loehr1
1Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Abstract:
Testicular germ cell tumors (TGCTs) are among the most curable solid cancers and are typically highly responsive to conventional DNA-damaging chemotherapies, even in patients with metastatic disease. It has therefore been of great interest to understand the basis for the unique chemosensitivity of these cancers, which is linked to the DNA damage sensitivity of their cancer stem cells. TGCTs have been difficult to study in the mouse, however, since most of the existing mouse models develop benign teratomas that are unlike the malignant TGCTs that afflict most testicular cancer patients. We describe here methods for generating a TGCT mouse model that closely resembles the malignant, metastatic disease observed in men with testicular cancer, and additionally include methods for analyzing the cancer stems cells and responses to chemotherapeutics in these murine TGCTs.
Insights
Developing new mouse models for testicular germ cell tumors (TGCTs) allows for better study of their unique chemosensitivity. These models mimic malignant, metastatic human TGCTs, aiding research into cancer stem cells and treatment responses.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Testicular germ cell tumors (TGCTs) are highly curable and chemosensitive solid cancers.
- Understanding TGCT chemosensitivity is linked to cancer stem cell DNA damage sensitivity.
- Existing mouse models often develop benign teratomas, not accurately reflecting malignant human TGCTs.
Purpose of the Study:
- To develop a novel mouse model that accurately recapitulates malignant, metastatic TGCTs.
- To establish methods for analyzing cancer stem cells within these murine TGCT models.
- To investigate responses to chemotherapeutics in a relevant TGCT mouse model.
Main Methods:
- Generation of a new TGCT mouse model.
- Analysis of cancer stem cells in the developed model.
- Assessment of chemotherapeutic responses in murine TGCTs.
Main Results:
- Successfully generated a TGCT mouse model that mirrors human malignant and metastatic disease.
- Established methodologies for studying cancer stem cells and treatment efficacy in this model.
- Provided a platform for further research into TGCT biology and therapy.
Conclusions:
- The developed mouse model offers a significant advancement for studying TGCTs.
- This model facilitates deeper understanding of TGCT cancer stem cells and their chemosensitivity.
- It enables more effective preclinical testing of novel therapeutic strategies for testicular cancer.
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:16In-vitro Mutagenesis